Myo-inositol as Pretreatment in Hyperandrogenic PCOS Patients
Status:
Unknown status
Trial end date:
2020-04-01
Target enrollment:
Participant gender:
Summary
A randomized controlled trial to evaluate whether pretreatment with myo-inositol can lower
testosterone levels and improve clinical outcomes in hyperandrogenic PCOS patients undergoing
ART